Compare Stocks → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:ECXNYSE:NTGTSE:SGFCNSX:VP Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeECXECARX$1.93-1.0%$2.43$1.87▼$9.34$72.38M0.290,852 shs8,772 shsNTGTortoise Midstream Energy Fund$37.70+0.1%$35.79$31.25▼$37.95N/AN/A13,862 shs275 shsSGF812575 (SGF.TO)C$0.18C$0.15▼C$0.44C$68.09MN/A169,986 shs73,804 shsVPVodis Pharmaceuticals$0.00$0.16▼$0.62N/AN/A1,714 shs51,582 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceECXECARX+1.56%-4.88%-30.85%-32.53%-62.79%NTGTortoise Midstream Energy Fund+0.94%+0.40%+6.15%+7.63%+17.55%SGF812575 (SGF.TO)0.00%0.00%0.00%0.00%0.00%VPVodis Pharmaceuticals0.00%0.00%0.00%0.00%0.00%Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationECXECARX1.5383 of 5 stars3.52.00.00.03.30.80.0NTGTortoise Midstream Energy Fund0.3548 of 5 stars0.04.00.00.02.11.70.0SGF812575 (SGF.TO)N/AN/AN/AN/AN/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceECXECARX3.00Buy$10.00418.13% UpsideNTGTortoise Midstream Energy FundN/AN/AN/AN/ASGF812575 (SGF.TO)N/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookECXECARX$657.10M0.11N/AN/A($3.13) per share-0.62NTGTortoise Midstream Energy Fund$9.46MN/AN/AN/AN/AN/ASGF812575 (SGF.TO)N/AN/AN/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateECXECARX-$132.60M-$0.38N/A∞N/A-20.03%N/A-23.13%6/10/2024 (Estimated)NTGTortoise Midstream Energy FundN/A-$0.03N/A∞N/AN/AN/AN/AN/ASGF812575 (SGF.TO)N/AN/A0.00N/AN/AN/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/A0.00N/AN/AN/AN/AN/AN/ALatest SGF, EHL, ECX, VP, and NTG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/28/2024Q4 2023ECXECARXN/A-$0.12-$0.12-$0.12N/A$263.10 million DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthECXECARXN/AN/AN/AN/AN/ANTGTortoise Midstream Energy Fund$3.088.17%+1.22%N/A N/ASGF812575 (SGF.TO)C$0.28N/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/AN/AN/AN/ALatest SGF, EHL, ECX, VP, and NTG DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/7/2024NTGTortoise Midstream Energy Fundquarterly$0.779%2/21/20242/22/20242/29/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioECXECARXN/A0.780.74NTGTortoise Midstream Energy FundN/AN/AN/ASGF812575 (SGF.TO)N/AN/AN/AVPVodis PharmaceuticalsN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipECXECARXN/ANTGTortoise Midstream Energy FundN/ASGF812575 (SGF.TO)N/AVPVodis PharmaceuticalsN/AInsider OwnershipCompanyInsider OwnershipECXECARX20.00%NTGTortoise Midstream Energy FundN/ASGF812575 (SGF.TO)N/AVPVodis PharmaceuticalsN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableECXECARX1,50137.50 million30.00 millionNot OptionableNTGTortoise Midstream Energy FundN/AN/AN/ANot OptionableSGF812575 (SGF.TO)147,000378.28 millionN/ANot OptionableVPVodis PharmaceuticalsN/AN/AN/ANot OptionableSGF, EHL, ECX, VP, and NTG HeadlinesSourceHeadlineCOVETRUS® TRANSFORMS PRESCRIPTION MANAGEMENT FOR VETERINARY PRACTICES WITH INTRODUCTION OF vRxPro™tmcnet.com - March 27 at 1:27 PMStates' drug pricing boards off to a slow startmsn.com - March 22 at 8:16 AMGLP-1s set to take drug sales throne from PD-1 inhibitors in 2024mmm-online.com - March 20 at 6:45 PMVerrica Pharmaceuticals Set to Discuss Q4 and Full-Year 2023 Financial Results in Upcoming Conference Callmsn.com - February 25 at 2:28 PMAbivax appoints Ana Sharma as Vice President, Global Head of Qualitymarkets.businessinsider.com - February 7 at 8:56 AMMedicines360 Appoints Lisa David as Chair of the Board of Directors, Strengthening its Commitment to Women’s Healthmarkets.businessinsider.com - January 24 at 1:10 PMSenior Vice Presidentgovtech.com - December 20 at 9:06 AMDr Reddy's becomes sole Indian pharma player to make it to Dow Jones Sustainability World Index 2023msn.com - December 14 at 3:30 PMBiden warns Big Pharma: Make your drugs cheaper or the US government will override your patentsmsn.com - December 7 at 3:45 PMThe White House is threatening the patents of high-priced drugs developed with taxpayer dollarsabcnews.go.com - December 7 at 9:38 AMAmneal Pharma in pact with Strides to launch generic Vascepamsn.com - December 1 at 3:25 PMAnavex Life Sciences Appoints Senior VP of Regulatory Affairsmarkets.businessinsider.com - November 6 at 8:21 AMXpeng's vice president suspended amid corruption investigation in supply chain managementfoxnews.com - October 14 at 11:38 PMLexicon Pharmaceuticals Up 20% on Express Scripts Designation for Inpefa Heart Drugmarketwatch.com - October 9 at 6:33 PMStrengthening of vertical integration: Exyte completes acquisition of pure media specialist Integamarkets.businessinsider.com - October 4 at 6:44 AMVice Presidentnewsweek.com - September 19 at 1:02 PMRepublican voters want Donald Trump. And his vice president? How about more Trump?usatoday.com - August 28 at 4:23 AMTeva Pharmaceuticals to pay $225M fine to settle price-fixing chargesnews.yahoo.com - August 22 at 4:12 AMVertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcriptmsn.com - August 1 at 10:03 PMSee which pharma brands are the strongest and fastest-growing in 2023mmm-online.com - July 12 at 1:54 PMSenior Vice President, Corporate Development and Global Strategywebmd.com - June 9 at 11:51 PMWhat has Kamala Harris done as vice president?news.yahoo.com - May 29 at 8:36 AMAHIP Marketing Campaign Targets Pharma’s Prescription Drug Pricinghealthpayerintelligence.com - April 24 at 7:41 PMMeet our President and Vice Chancellorlse.ac.uk - April 9 at 10:43 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsECARXNASDAQ:ECXECARX Holdings Inc. develops a full stack automotive computing platform to reshape the mobility market worldwide. Its principal products include infotainment head units, digital cockpits, and vehicle chip-set solutions, as well as core operating system and integrated software stack. The company was founded in 2017 and is based in London, the United Kingdom.Tortoise Midstream Energy FundNYSE:NTGTortoise MLP Fund, Inc. is a close ended equity mutual fund launched and managed by Tortoise Capital Advisors L.L.C. It invests in public equity markets. The fund primarily invests in equity securities of MLPs and their affiliates, with an emphasis on natural gas infrastructure Master Limited Partnerships. It employs a fundamental analysis with a bottom up stock picking approach with focus on factors like quantitative, qualitative, and relative value factors to create its portfolio. Tortoise MLP Fund, Inc. was formed on July 27, 2010 is domiciled in United States.812575 (SGF.TO)TSE:SGFShore Gold Inc. is a Canada-based company, which is engaged in the exploration, development and production of diamonds. The Company's mineral property holdings include the Star Kimberlite Property (Project), which is located in the central part of Saskatchewan, Canada; the Fort a la Corne Joint Venture (FALC-JV) Property, which is located in central Saskatchewan, Canada, and Buffalo Hills Joint Venture, which is located in central Alberta, Canada. The Company's Star-Orion South Diamond Project includes the Star Diamond Project, as well as Star West and the Orion South Kimberlite. The Company acts as an operator of the FALC-JV. The Company's subsidiaries include Shore Mining & Development Corp. and Kensington Resources Ltd.Vodis PharmaceuticalsCNSX:VPVodis Pharmaceuticals Inc. operates as an application stage company for producing medical marijuana. It operates in Canada and the United States. The company is based in Delta, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.